Physician profile
Sameh M Ragheb
NPI 1295769404
$718.52
in general payments reported to CMS, 2019-2025
13 companies · $16.92 in 2025
The $16.92 reported for 2025 was less than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $369 · 2020: $332 · 2025: $16.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.92.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $160.55 | 2019-2020 | |
| Allergan, INC. | $116.52 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $84.80 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $62.65 | 2019-2025 | Spravato |
| Neurocrine Biosciences, INC. | $56.97 | 2019-2020 | |
| Alkermes, INC. | $55.87 | 2019 | |
| Vanda Pharmaceuticals INC. | $41.00 | 2019-2020 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $30.58 | 2019 | |
| Lundbeck LLC | $29.74 | 2019 | |
| Ironshore Pharmaceuticals INC. | $29.39 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.94 | 2019 | |
| Kaleo, INC. | $14.39 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $14.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameh Ragheb listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.